# ALKEM share price, delivery % and history — Alkem Laboratories Limited

> Delivery percentage for Alkem Laboratories Limited (ALKEM) against its own history, with 2,665 sessions of split-adjusted NSE data from 2015 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/ALKEM

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 5,163.5 INR (-1.65% on the day), 2026-09-30
- Delivery: 63.35% of volume taken to demat (20-day average 58.31%)
- Volume: 1.47L shares, turnover ₹75.7Cr
- Relative volume: 0.94× of its own 20-day average

## Technicals

- RSI(14): 42.25
- ATR(14): 127.67
- SMA 50: 5,403.38, SMA 200: 5,488.31
- 52-week range: 5,051 – 5,933.5 (-12.98% from the high)

## Performance

- 1 week -4.69%, 1 month -3.11%, 3 months -6.13%
- 6 months -3.39%, 1 year -6.87%

## Delivery percentage

- Latest: 63.35% (2026-09-30)
- 20-day average: 58.31%
- 1-year average: 54.85%
- Percentile against its own history: 77th
- Range: 10.89% – 94.15% across 1,728 sessions with a reading

Over the last 20 sessions ALKEM settled 58.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 54.9%, so recent sessions are running 3.5 points higher than usual. The latest session ranks higher than 77% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 61,737.4 crore
- P/E (TTM): 28.01 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 184.35 INR, split-adjusted to match the price series
- Revenue growth: 10.95% YoY, 3.8% QoQ
- Profit growth: -22% YoY, 107.47% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 8.84% | 3.09% |
| 3y | 7.94% | 23.75% |
| 6y | 10.03% | 8.05% |
| 7y | 10.39% | 15.1% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 3,414.7 | 2,768.9 | 780.3 | 702 | 57.6 | 20.56% |
| 2024-12-31 | 3,374.3 | 2,736.2 | 731.1 | 640.8 | 52.34 | 18.99% |
| 2025-03-31 | 3,143.8 | 2,893.4 | 396.3 | 322.4 | 25.57 | 10.25% |
| 2025-06-30 | 3,371.1 | 2,749.6 | 771 | 667.9 | 55.56 | 19.81% |
| 2025-09-30 | 4,001 | 3,208.9 | 895.8 | 779.1 | 63.99 | 19.47% |
| 2025-12-31 | 3,736.8 | 3,045.9 | 781.2 | 653 | 53.19 | 17.48% |
| 2026-03-31 | 3,603.3 | 3,245.6 | 422.9 | 251.1 | 19.77 | 6.97% |
| 2026-06-30 | 3,740.2 | 3,120.9 | 772 | 521 | 43.49 | 13.93% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 49.7%
- Public: 50.3%
- FII: 10.42%, DII: 22.63%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-14: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_187455_14082026175149_iXBRL_WEB.html
- 2026-08-07: dividend
- 2026-07-09: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1689784_09072026041014_WEB.xml
- 2026-05-28: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_163069_28052026200517_iXBRL_WEB.html
- 2026-04-15: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1651248_15042026031216_WEB.xml
- 2026-02-20: dividend
- 2026-02-13: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_143026_13022026174414_iXBRL_WEB.html
- 2026-01-13: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1599320_13012026111044_WEB.xml

Dated by the day the company broadcast the filing. 87 events are indexed for this instrument.

## About the instrument

- Listed: 2015-12-23 — latest session 2026-09-30 (2,665 sessions)
- ISIN: INE540L01014
- Series: EQ
- Liquidity rank: #348 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/ALKEM.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.